Betazen’ Herbal Formulation, Ameliorates Experimentally Induced Metabolic Disturbances in Insulin Resistant Rats
Abstract
The present study was designed to evaluate anti-diabetic activity of ayurvedic formulation ‘Betazen’ in experimentally induced insulin resistant rats. Wistar rats were being rendered insulin resistant by administration of dexamethasone (2 μg/day s.c), along with high fat-high sugar (HFHS) diet (i.e. vanaspati ghee and fructose enriched) for 42 days. Animals with fasting blood glucose levels (BGL) of more than 150 mg/dl were selected, divided into different groups and administered 2.7 mg/kg pioglitazone, 45 mg/kg, and 90 mg/kg betazen herbal formulation (BHF) respectively, suspended in 1% CMC for 30 days p.o. At the end of the study, animals were sacrificed; blood was collected and used for estimation of various biochemical parameters and HbA1c. Whereas, glycogen content in the liver and gastrocnemius muscle, glucose uptake in hemi-diaphragm and antioxidant biomarkers in liver were also estimated. Pancreas were subjected for histopathological studies. The results obtained from the present study exhibited a significant dose dependent decrease in elevated fasting BGL, lipids (TC, TG, HDL, LDL and VLDL), HbA1c and MDA levels. Further, there was a significant (p<0.001) increase in glycogen content, glucose uptake, HDL, and antioxidant biomarkers viz.; GSH, SOD and CAT. These experimental results highlighted the antioxidant, anti-glycation and anti-hyperglycemic potential of BHF on insulin resistance. It further exhibited an improvement in dyslipidemia, insulin sensitivity, and glycogen content. Hence, BHF could be a promising future herbal treatment for insulin resistance type-2 diabetes mellitus.
Keywords: Insulin resistance, dexamethasone, high fat-high sugar, betazen
Cite this Article
Khatib Nayeem A, Caiado Ira CS, Patil Srinivas M et al. ‘Betazen’ Herbal Formulation, Ameliorates Experimentally Induced Metabolic Disturbances in Insulin Resistant Rats. Research & Reviews: A Journal of Pharmacology. 2016; 6(2): 13–23p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |